copd Clinical Trials and Research
Also known as: emphysema, chronic bronchitis, smoker's lung, chronic obstructive lung disease, airflow obstruction · ICD-10: J44
Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that makes breathing difficult. Clinical trials are actively researching new ways to manage symptoms, slow disease progression, and improve quality of life for patients. Find a Trial helps patients and caregivers search for active studies.
Common questions about copd clinical trials
Who can participate in COPD clinical trials?
Eligibility criteria vary by study, often including age, COPD severity, and overall health status. Researchers use these criteria to ensure patient safety and collect relevant data. Patients should discuss their medical history with the research team to see if they qualify for a study.
What are the different phases of COPD clinical trials?
Clinical trials typically progress through phases 1 to 4. Early phases focus on safety and dosage, while later phases evaluate effectiveness and compare new treatments to existing ones. Data from ClinicalTrials.gov show many studies in various phases, each with distinct goals and participant numbers.
Do COPD clinical trials cost money to participate?
Generally, participants do not pay for study-related treatments or visits. Some trials may even offer compensation for time and travel. However, standard medical care not part of the study may still be billed to insurance or the participant, so it's important to clarify costs.
What new treatments are being studied for COPD?
Current research, as seen on ClinicalTrials.gov and NIH RePORTER, explores novel bronchodilators, anti-inflammatory drugs, and therapies targeting specific disease pathways. Studies also investigate non-pharmacological interventions like pulmonary rehabilitation, oxygen delivery methods, and digital health tools for better disease management.
What types of interventions are common in COPD clinical trials?
Common interventions include new medications like inhaled corticosteroids or bronchodilators, oxygen therapy, and pulmonary rehabilitation programs. Some trials also investigate surgical procedures or devices aimed at improving lung function. These interventions are carefully monitored and evaluated for safety and efficacy.
Are there specific biomarkers being studied in COPD trials?
Yes, researchers are investigating various biomarkers, such as inflammatory markers in blood or sputum, genetic factors, and imaging findings. These biomarkers could help predict disease progression, identify responders to therapy, or classify disease subtypes, according to NIH RePORTER data. This research aims to personalize treatment approaches.
What might prevent someone from joining a COPD trial?
Common exclusion criteria might include other serious medical conditions, recent lung infections, or current participation in another trial. Specific criteria ensure patient safety and the integrity of study results. Each trial lists its unique requirements on ClinicalTrials.gov, which potential participants should review carefully.
What are the potential benefits and risks of participating in a COPD trial?
Potential benefits include access to new treatments and close medical monitoring. Risks can involve side effects from experimental therapies or the need for frequent clinic visits. All potential benefits and risks are thoroughly explained before participation, as required by ethical guidelines and informed consent processes.
How to find a copd trial that fits you
- Describe your copd situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.